Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

STING agonist-12

Copy Product Info
🥰Excellent
Catalog No. T9853Cas No. 2259624-71-8

STING agonist-12 based on an oxindole core structure demonstrated robust on-target functional activation of STING (human EC50 185 nM) in immortalised and primary cells and a cytokine induction fingerprint consistent with STING activation.

STING agonist-12

STING agonist-12

Copy Product Info
🥰Excellent
Purity: 98.29%
Catalog No. T9853Cas No. 2259624-71-8
STING agonist-12 based on an oxindole core structure demonstrated robust on-target functional activation of STING (human EC50 185 nM) in immortalised and primary cells and a cytokine induction fingerprint consistent with STING activation.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$34In StockIn Stock
5 mg$80In StockIn Stock
10 mg$126In StockIn Stock
25 mg$263In StockIn Stock
50 mg$422In StockIn Stock
100 mg$628In StockIn Stock
200 mg$893In StockIn Stock
1 mL x 10 mM (in DMSO)$88In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.29%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

STING agonist-12 AI Summary
STING agonist-12 activates wild-type human STING and its various mutant versions, leading to the activation of the IRF3 reporter with an EC50 value of 185.0 nM. It also shows inhibitory activity against human ERG. In BALB/c mice, the compound demonstrates significant bioavailability and pharmacokinetic properties, including relatively high oral bioavailability and favorable distribution characteristics..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
STING agonist-12 based on an oxindole core structure demonstrated robust on-target functional activation of STING (human EC50 185 nM) in immortalised and primary cells and a cytokine induction fingerprint consistent with STING activation.
Targets&IC50
STING:185 nM (EC50)
Chemical Properties
Molecular Weight490.88
FormulaC25H19ClF4N2O2
Cas No.2259624-71-8
SmilesCC1(C)C(=O)N(Cc2c(F)cccc2Cl)c2cc(ccc12)C(=O)NCc1c(F)cc(F)cc1F
Relative Density.1.392 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 60 mg/mL (122.23 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.0372 mL10.1858 mL20.3716 mL101.8579 mL
5 mM0.4074 mL2.0372 mL4.0743 mL20.3716 mL
10 mM0.2037 mL1.0186 mL2.0372 mL10.1858 mL
20 mM0.1019 mL0.5093 mL1.0186 mL5.0929 mL
50 mM0.0407 mL0.2037 mL0.4074 mL2.0372 mL
100 mM0.0204 mL0.1019 mL0.2037 mL1.0186 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy STING agonist-12 | purchase STING agonist-12 | STING agonist-12 cost | order STING agonist-12 | STING agonist-12 chemical structure | STING agonist-12 formula | STING agonist-12 molecular weight